Details for New Drug Application (NDA): 217294
✉ Email this page to a colleague
NDA 217294 describes LASIX ONYU, which is a drug marketed by Sq Innovation and is included in one NDA. It is available from one supplier. Additional details are available on the LASIX ONYU profile page.
The generic ingredient in LASIX ONYU is furosemide. There are twenty-two drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the furosemide profile page.
The generic ingredient in LASIX ONYU is furosemide. There are twenty-two drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for 217294
| Tradename: | LASIX ONYU |
| Applicant: | Sq Innovation |
| Ingredient: | furosemide |
| Patents: | 0 |
Pharmacology for NDA: 217294
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 217294
Suppliers and Packaging for NDA: 217294
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LASIX ONYU | furosemide | SOLUTION;SUBCUTANEOUS | 217294 | NDA | SQ Innovation, Inc. | 81137-001 | 81137-001-15 | 1 CARTON in 1 KIT (81137-001-15) / 1 CARTRIDGE in 1 CARTON / 2.67 mL in 1 CARTRIDGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 80MG/2.67ML (30MG/ML) | ||||
| Approval Date: | Oct 7, 2025 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
